Pep1-TGL

Pep1-TGL is a synthetic peptide designed to facilitate the intracellular delivery of various bioactive molecules, including proteins, peptides, and nucleic acids. As a member of the cell-penetrating peptide (CPP) family, it is characterized by its ability to traverse cellular membranes efficiently without causing significant cytotoxicity or membrane disruption. The unique amino acid sequence of Pep1-TGL enables it to form non-covalent complexes with cargo molecules, thereby enhancing their solubility and stability in biological environments. Its robust membrane-translocating properties and low immunogenicity make it a valuable tool for researchers seeking to explore intracellular mechanisms, modulate cellular pathways, or deliver experimental probes in both in vitro and ex vivo systems.

Intracellular Delivery: Pep1-TGL is widely employed as a molecular carrier for delivering peptides, proteins, and other macromolecules into living cells. Its amphipathic structure allows for efficient complexation with diverse cargo types, facilitating their passage across the plasma membrane via energy-independent mechanisms. This application is particularly significant in studies where direct cytosolic access is required, such as enzyme replacement assays, protein-protein interaction mapping, or the functional analysis of intracellular signaling components. Researchers benefit from its ability to bypass endosomal entrapment, thereby ensuring that the delivered molecules reach their intended subcellular targets with high efficiency.

Gene and Oligonucleotide Transfer: The peptide's cell-penetrating capacity extends to the delivery of nucleic acids, including small interfering RNA (siRNA), antisense oligonucleotides, and plasmid DNA. By forming stable, non-covalent complexes with these genetic materials, Pep1-TGL enables their direct internalization and subsequent engagement with intracellular machinery. This property is leveraged in gene silencing experiments, gene expression studies, and the development of advanced transfection protocols, providing researchers with a versatile tool for modulating gene function in a variety of cell types.

Peptide Functional Studies: Due to its compatibility with a range of peptide cargoes, Pep1-TGL is instrumental in investigating the intracellular activity of bioactive peptides. By facilitating their entry into the cytosol, the carrier supports studies on peptide-mediated signal transduction, receptor activation, and intracellular enzyme modulation. This application is particularly valuable for dissecting the mechanisms of action of therapeutic peptides, studying peptide-protein interactions, and screening peptide libraries for biological activity in cellular models.

Protein Trafficking and Localization: The ability of Pep1-TGL to deliver full-length proteins or protein fragments into cells makes it a powerful tool for tracking protein localization, monitoring trafficking dynamics, and assessing the functional consequences of protein delivery in real time. Researchers utilize this capability to study the spatial and temporal regulation of proteins within live cells, investigate the impact of post-translational modifications, or validate antibody specificity by delivering epitope-tagged constructs.

Assay Development and High-Content Screening: The use of Pep1-TGL in the development of cell-based assays and high-content screening platforms is well established. By enabling the controlled introduction of functional biomolecules into cellular systems, it supports the creation of robust, reproducible assays for drug discovery, target validation, and pathway analysis. Its compatibility with a wide range of cell types and experimental formats enhances the flexibility and scalability of screening workflows, allowing for more comprehensive and physiologically relevant data acquisition in early-stage research and development programs.

1. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis